ATC J05AG04 · Non-Nucleoside Reverse Transcriptase Inhibitors · updated 2 Nov 2026

Etravirine shortage

As of 2 Nov 2026, Etravirine has a reported shortage in 1 of the 16 countries we track (United States), covering 2 products from 1 company.

Is there an Etravirine shortage?

Yes. As of 2 Nov 2026, Etravirine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

Countries1/16

Products2packs or presentations

Companies11 listed

Short since28 Apr 20266 months ago

Earliest returnnot givencompany estimate

Main reasonNot stated

United States

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

products short, all countries

Listed: Johnson & Johnson JNJ · NYSE

ATC group J05AG · Non-Nucleoside Reverse Transcriptase Inhibitors

Country	Product	Company	Since	Expected back	Reason
US	Etravirine, Tablet, 100 mg (NDC 10147-0570-1) discontinuation	Janssen Research and Development	28 Apr 2026	not given	Not stated
US	Intelence, Tablet, 100 mg (NDC 59676-570-01) discontinuation	Janssen Research and Development	28 Apr 2026	not given	Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Is there an Etravirine shortage?

Yes. As of 2 Nov 2026, Etravirine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

When will Etravirine be back in stock?

No return date has been given; United States: no date given. These are company estimates reported to each authority.

Why is Etravirine in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Etravirine shortages?

Johnson & Johnson.